Related Experiment Video
Updated: Jun 20, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Factors that deregulate the protective immune response in tuberculosis
Rogelio Hernandez-Pando1, Hector Orozco, Diana Aguilar
1Experimental Pathology Section, Department of Pathology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Tlalpan, Mexico City, CP-14000, México. rhpando@quetzal.innsz.mx
Tuberculosis (TB) disease involves lung infections and immune system dysfunction. Factors that suppress the immune response can worsen TB, highlighting potential immunotherapy targets.
Area of Science:
- * Immunology
- * Infectious Diseases
- * Microbiology
Background:
- * Tuberculosis (TB) is a chronic infectious disease primarily affecting the lungs.
- * While most infected individuals remain asymptomatic, immune system alterations (e.g., HIV, malnutrition, diabetes) increase active TB risk.
- * Active TB disease can suppress Mycobacterium tuberculosis-specific immune responses, even without immunosuppressive conditions.
Purpose of the Study:
- * To review key participants in protective immunity against tuberculosis.
- * To identify factors that deregulate protective immunity during active TB.
- * To briefly discuss the potential of manipulating these factors for novel immunotherapy.
Main Methods:
- * Literature review of immune responses in tuberculosis.
- * Analysis of factors contributing to immune suppression in TB.
- * Examination of potential immunotherapeutic strategies.
Main Results:
- * Several immune factors, often anti-inflammatory, are implicated in downregulating protective immunity.
- * Overproduction of these factors can paradoxically facilitate Mycobacterium tuberculosis growth and disease progression.
- * Both protective and deregulating immune mechanisms in TB are significant.
Conclusions:
- * Understanding immune dysregulation in TB is crucial for disease management.
- * Identifying factors that suppress protective immunity offers targets for novel immunotherapies.
- * Manipulating immune responses holds promise for future TB treatment strategies.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

